• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    DCAT Week ’19

    Temperature-Controlled Logistics

    Reducing Pill Burden

    Nasal Drug Delivery

    AI in Pharma: Transforming Data into Drugs
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    BASi Appoints COO

    Nestlé Health Licenses Codexis’ CDX-6114

    SK, Arvelle Sign $530M Deal for Antiepileptic Drug

    GS1 Delivers Lightweight Messaging Standard For Verification of Product Identifiers

    Progenics Launches Mfg. Ops in NJ
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Progenics Launches Mfg. Ops in NJ

    Pelican BioThermal Opens New Network Location

    Reed-Lane Facility Tour

    Haselmeier Acquires Drug Manufacturing License

    Emerald Health, Lonza Enter Large-Scale Mfg. Pact
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    GS1 Delivers Lightweight Messaging Standard For Verification of Product Identifiers

    Pelican BioThermal Opens New Network Location

    Reed-Lane Facility Tour

    Recipharm Facilities Ready for EU Serialization

    Andrew Alliance, Sartorius Launch Research Solution
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Nestlé Health Licenses Codexis’ CDX-6114

    Personalized Medicine: Getting More Out of Clinical Trials

    SK, Arvelle Sign $530M Deal for Antiepileptic Drug

    Charles River to Pay $510M for Citoxlab

    West, Swissfillon Enter Drug Delivery Partnership
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Former FDA Senior Executives Join PAREXEL

    Top Global Pharma Company to Implement ValGenesis' VLMS

    WCG, Prudentia Enter Pharmacovigilance Alliance

    ValGenesis VLMS Chosen to Digitize Validation Process

    Serialization Compliance: Understanding the Challenges
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Baxter BioPharma Solutions

    Emergent BioSolutions, Inc.

    Federal Equipment Company

    Alcami

    Ajinomoto Bio-Pharma Services
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Reed-Lane, Inc.

    Ascendia Pharmaceuticals

    Alcami

    Aphena Pharma Solutions, Inc.

    Federal Equipment Company
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
      • Top 20 Pharma & BioPharma
      • Top 10 BioPharma Companies
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Agenda
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Particle Sciences Appoints President

    Dr. Robert Lee has a decade of service at the company, most recently as executive vice president of Pharmaceutical Services

    Related CONTENT
    • Tergus Pharma Acquires EnDev Laboratories
    • Changing Dynamics: The CDMO market in focus
    • Bioclinica Announces Key Hires & Promotion
    • PAREXEL Appoints Chief Commercial Officer
    • Thermo Fisher Inks New Agreements with Daiichi and Takeda
    09.13.18
    Particle Sciences has announced the appointment of Dr. Robert Lee to president.

    With a decade of service at the company, most recently as executive vice president of Pharmaceutical Services, and 17 years overall, Dr. Lee has been instrumental in the business’ growth and current position as a leading CDMO for complex drug products.  His new role as president will enable him to continue to increase Particle Sciences’ growth by expanding the company’s technical capabilities while continuing its commitment to executing client projects on time and budget. 

    Since Particle Sciences was acquired by Lubrizol in 2015, the business has experienced continued growth.  Average sales have increased by 20 percent year-over-year since the acquisition due in part to the development and manufacturing of insoluble, sterile and highly potent drug products. The company is currently investing in its complex drug manufacturing capabilities and is due to announce the opening of a state-of-the-art drug product manufacturing facility in the coming months, part of an overall $60 million LifeSciences business unit investment. 

    This new space will leverage the company's knowledge of complex formulations and drug product manufacturing, accommodating both sterile and non-sterile finished drug products, such as ophthalmics, drug-device combination products, injectables, micro- and nanoparticulate formulations and lyophilized drugs.

    Barbara Morgan, general manager of Particle Sciences states, “Robert comes to this position with extensive industry experience and company knowledge and takes the helm at a very exciting time for the business. As we further expand our facilities and strengthen our service offering, we look forward to continued success as the Particle Sciences’ team works under Robert’s leadership.”  
    Related Searches
    • executive vice president
    • CDMO
    • acquisition
    • Sterile
    Suggested For You
    Finding the Right Partner Finding the Right Partner
    Codiak BioSciences Appoints EVP Codiak BioSciences Appoints EVP
    Catalent, Aucta Pharma Ink Commercial Mfg. Pact Catalent, Aucta Pharma Ink Commercial Mfg. Pact
    Robert Lee Named President of CDMO Particle Sciences Robert Lee Named President of CDMO Particle Sciences
    Amgen Reveals Executive Transition Plans Amgen Reveals Executive Transition Plans
    PPD Names New CHRO PPD Names New CHRO
    Amgen, UCB Resubmit BLA Amgen, UCB Resubmit BLA
    LabConnect Names COO LabConnect Names COO
    Ardena Strengthens API Offering Ardena Strengthens API Offering
    PPD Appoints CFO PPD Appoints CFO
    Thermo Fisher Inks New Agreements with Daiichi and Takeda Thermo Fisher Inks New Agreements with Daiichi and Takeda
    PAREXEL Appoints Chief Commercial Officer PAREXEL Appoints Chief Commercial Officer
    Bioclinica Announces Key Hires & Promotion Bioclinica Announces Key Hires & Promotion
    Changing Dynamics: The CDMO market in focus Changing Dynamics: The CDMO market in focus
    Tergus Pharma Acquires EnDev Laboratories Tergus Pharma Acquires EnDev Laboratories

    Related Breaking News

    • Breaking News | Promotions & Moves
      BASi Appoints COO

      BASi Appoints COO

      Oakley responsible for leading operations at BASi’s three sites in West Lafayette and Evansville, IN, and St. Louis, MO
      02.19.19

    • Breaking News | Drug Development | Industry News
      Nestlé Health Licenses Codexis’ CDX-6114

      Nestlé Health Licenses Codexis’ CDX-6114

      Novel, oral enzyme for phenylketonuria is Codexis’ first internally developed biotherapeutic candidate
      02.19.19

    • Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News
      SK, Arvelle Sign $530M Deal for Antiepileptic Drug

      SK, Arvelle Sign $530M Deal for Antiepileptic Drug

      Mark Altmeyer named president and chief executive of Arvelle
      02.15.19


    • Breaking News | Industry News | Packaging & Tracking | Serialization | Supply Chain
      GS1 Delivers Lightweight Messaging Standard For Verification of Product Identifiers

      GS1 Delivers Lightweight Messaging Standard For Verification of Product Identifiers

      Streamlined framework leverages GS1 Digital Link and JavaScript Object Notation (JSON)
      02.15.19

    • Breaking News | Facilities | Industry News
      Progenics Launches Mfg. Ops in NJ

      Progenics Launches Mfg. Ops in NJ

      Acquires Azedra radiopharmaceutical manufacturing facility in Somerset
      02.15.19

    • Breaking News | CRO News | Industry News | Preclinical Outsourcing
      Charles River to Pay $510M for Citoxlab

      Charles River to Pay $510M for Citoxlab

      Strengthens position in early-stage CRO space
      02.15.19


    • Breaking News | Collaborations & Alliances | Drug Delivery | Industry News
      West, Swissfillon Enter Drug Delivery Partnership

      West, Swissfillon Enter Drug Delivery Partnership

      Partner on integrated solution for clinical filling of SmartDose drug delivery platform cartridges
      02.15.19

    • Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
      Jubilant Biosys, Sanofi Expand Collaboration

      Jubilant Biosys, Sanofi Expand Collaboration

      Collaboration aimed at discovery of small molecule inhibitors targeting neurological disorders
      02.15.19

    • Bio News | Industry News | Promotions & Moves | Regulatory Affairs
      Former FDA Senior Executives Join PAREXEL

      Former FDA Senior Executives Join PAREXEL

      The industry veterans will work on the company's Regulatory Consulting group
      02.15.19


    • Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | Laboratory Testing | R&D
      Passage Bio Officially Launches

      Passage Bio Officially Launches

      With $115.5M Series A, to develop AAV-delivered therapeutics to treat rare monogenic CNS diseases
      02.15.19

    • Bio News | Collaborations & Alliances | Drug Development | Industry News | Methods Development | R&D
      Axovant Announces Formation of Arvelle Therapeutics

      Axovant Announces Formation of Arvelle Therapeutics

      Along with the strategic transition of legacy small molecule team into the newly formed company
      02.15.19

    • Bio News | Cold Chain Management | Facilities | Industry News | Supply Chain
      Pelican BioThermal Opens New Network Location

      Pelican BioThermal Opens New Network Location

      New facility in Jeddah, Saudi Arabia aims to bring convenient, flexible shipping options to the region renowned for its temperature challenges
      02.15.19

    • Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
      AbCellera & Novartis Announce Collaboration

      AbCellera & Novartis Announce Collaboration

      AbCellera to apply technology to advance programs on up to ten targets elected by Novartis
      02.15.19

    • Financial Reports
      Financial Report: BASi

      Financial Report: BASi

      Seventh Wave acquisition drives growth in the quarter
      02.14.19

    • Breaking News | Financial Reports
      Financial Report: West Pharmaceutical Services

      Financial Report: West Pharmaceutical Services

      Revenues up 2% in the quarter, partially offset by the voluntary recall of Vial2Bag
      02.14.19

    Breaking News
    • BASi Appoints COO
    • Nestlé Health Licenses Codexis’ CDX-6114
    • SK, Arvelle Sign $530M Deal for Antiepileptic Drug
    • GS1 Delivers Lightweight Messaging Standard For Verification of Product Identifiers
    • Progenics Launches Mfg. Ops in NJ
    View Breaking News >
    CURRENT ISSUE

    January/February 2019

    • DCAT Week ’19
    • Temperature-Controlled Logistics
    • Reducing Pill Burden
    • Nasal Drug Delivery
    • AI in Pharma: Transforming Data into Drugs
    • Digitization: Pharma 4.0
    • Serialization Compliance: Understanding the Challenges
    • FDA & Data Integrity
    • Rising Demand for Lyophilized Products
    • Future Trends in the CDMO Space
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • privacy policy
    • term and condition
    • about us
    • contact us

    follow us

    Subscribe

    magazines

    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login